BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I/II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER

被引：0
|
作者：
OREILLY, SE
GELMON, KA
机构：
来源：
SEMINARS IN ONCOLOGY | 1995年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [21] Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial
    Xu, Binghe
    Jiang, Zefei
    Kim, Sung-Bae
    Yu, Shiying
    Feng, Jifeng
    Malzyner, Artur
    del Giglio, Auro
    Chung, Hyun C.
    Shen, Li Jun
    Pen, Daniel Lee Kay
    BREAST CANCER, 2011, 18 (03) : 203 - 212
  • [22] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [23] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [25] A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results
    Brufsky, A. M.
    Hoelzer, K. L.
    Keaton, M. R.
    Beck, J. T.
    Krill-Jackson, E.
    Wang, Y.
    Hu, S.
    Vaughn, L. G.
    Shonukan, O. O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390
  • [27] PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER
    VANDERGAAST, A
    BONTENBAL, M
    PLANTING, AST
    KOK, TC
    SPLINTER, TAW
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 858 - 860
  • [28] Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer
    Baltali, E
    Altundag, MK
    Güler, N
    Özisik, Y
    Firat, D
    Baran, I
    Tekuzman, G
    TUMORI, 2002, 88 (03) : 200 - 203
  • [29] Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer
    Kevin R. Fox
    Current Oncology Reports, 2009, 11 : 5 - 7
  • [30] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Jiang, Haiping
    Qian, Jiong
    Zhao, Peng
    Zhang, Xiaochen
    Zheng, Yi
    Mao, Chenyu
    Zheng, Yulong
    Chen, Linghong
    Wang, Yao
    Mou, Haibo
    Fang, Weijia
    Teng, Lisong
    Xu, Nong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 197 - 203
12345